chronic hepatitis B

hepatitis B virus

Biotech

GSK axes hepatitis B vaccine trial after missing efficacy goal

GSK ended the phase 1/2 trial after the therapeutic vaccine regimen missed the efficacy endpoint, denting its hopes of creating a functional cure.

Nick Paul Taylor Dec 4, 2024 5:15am

A double helix of DNA made up of musical notes The notes are in black against a grey-white background

Tune’s HBV therapy hits the right notes in cells and mice

Dec 7, 2023 2:05pm

The silhouette of a miner digging

Hepatitis B drug developers chart slow progress, just like hep C

Nov 14, 2023 9:05am

hepatitis B virus

Aligos culls another hep B asset over inconclusive efficacy data

Aug 4, 2023 7:27am

image of a chain with a padclock keeping a gate closed

Arbutus' oral checkpoint inhibitor slapped with clinical hold

Apr 25, 2023 11:00am

GSK

GSK sees hep B therapy's efficacy drop 60% in phase 2 readout

Nov 8, 2022 11:37am